Investor mix
10 investors on record; lead investors include Vida Ventures, Bayer.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 40% |
| Other / undisclosed | 6 | 60% |
Developer of T-cell therapies against oncogenic driver mutations
10 investors on record; lead investors include Vida Ventures, Bayer.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 40% |
| Other / undisclosed | 6 | 60% |